; Whereas those women who have a family history of ovarian or breast cancer should consider genetic testing and counseling to determine whether their risk of developing a heritable cancer is elevated; Whereas women who know that they are at high risk of ovarian cancer may undertake prophylactic measures like an opportunistic salpingectomy to help reduce the risk of developing this disease; Whereas guidelines issued by the NCCN and the Society of Gynecologic Oncology recommend that all individuals diagnosed with ovarian cancer receive genetic counseling and genetic testing regardless of their family history; Whereas studies consistently show that compliance with these guidelines is alarmingly low, with recently published National Cancer Institute-funded research finding that in 2013 and 2014, only one-third of ovarian cancer survivors have undergone such testing; Whereas, according to a 2016 consensus report by the National Academy of Medicine, there remain surprising gaps in the fundamental knowledge about and understanding of ovarian cancer across all aspects of the disease; Whereas ongoing investments in ovarian cancer research and education and awareness efforts are critical to closing these gaps and improving survivorship for women with ovarian cancer; Whereas each year during the month of September, the Ovarian Cancer Research Alliance and community partner organizations hold a number of events to increase public awareness of ovarian cancer and its symptoms; and Whereas September 2023 should be designated as National Ovarian Cancer Awareness Month to increase public awareness of ovarian cancer: Now, therefore, be it